Clorox said net sales for the quarter ended September 30, 2025 fell 19% to $1.43 billion. The company cited lower shipments tied to the ERP transition as the main factor, and organic sales declined 17%.

1. 01

   Clorox said net sales for the quarter ended September 30, 2025 fell 19% to $1.43 billion. The company cited lower shipments tied to the ERP transition as the main factor, and organic sales declined 17%.

2. 02

   The company said gross margin for Q1 was 410 basis points lower at 41.7%, compared with 45.8% in the year-ago quarter. It said diluted EPS was $0.65 (year-ago: $0.80) and adjusted EPS was $0.85 (year-ago: $1.86).

3. 03

   Clorox said year-to-date net cash provided by operations for Q1 was $93 million, down 58% from $221 million a year earlier. The company cited the impact of the ERP transition as a factor.

4. 04

   Clorox said it is maintaining its fiscal 2026 outlook for net sales to decline 6% to 10% and adjusted EPS of $5.95 to $6.30. The company said the impact of order fulfillment challenges means its current expectations are toward the lower end of the range.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.